跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 395 条关于
“AK+ Guard”
全部
395
临床试验
168
药物
136
机构
12
资讯
79
去年
AccurKardia's AI-Powered Hyperkalemia Detection Software Receives FDA Breakthrough Device Designation
2年前
GUARD-AF Trial: iRhythm's Zio XT Patch Increases AF Detection in Primary Care
2年前
First Patient Dosed in Guard Therapeutics' Phase 2b Study POINTER
去年
Philikos Initiates Phase 1/2 Trial of T-Guard for Diffuse Cutaneous Systemic Sclerosis
去年
Guard Therapeutics' POINTER Study Reaches 25% Enrollment Milestone
11个月前
Guard Therapeutics' RMC-035 Fails Phase 2b POINTER Trial Despite Earlier Positive Results
2年前
Guard Therapeutics' RMC-035 Shows Kidney-Protective Effect in Phase 2 Trial
去年
Guard Therapeutics Announces SEK 150M Rights Issue to Advance Kidney Protection Drug Development
去年
Boston Scientific Resumes Enrollment in AVANT GUARD Atrial Fibrillation Trial
去年
Tirbanibulin Shows Efficacy in Treating Actinic Keratosis Over Larger Skin Areas
第 1 页,共 8 页
上一页
下一页